Biocon Biologics gets US market entry date for Bmab 1200, a proposed biosimilar to Stelara
Stelara (Ustekinumab) has been approved for the treatment of psoriasis, Crohn’s disease, ulcerative colitis, plaque psoriasis and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Janssen
Cidara Therapeutics signs deal with Janssen for antiviral conjugates to prevent, treat influenza
Cidara will be responsible for the development and manufacturing of the first influenza AVC, CD388, into the clinic and through…
Janssen gets EC approval for expanded use of IMBRUVICA (ibrutinib) plus rituximab to treat CLL
Data from Phase 3 E1912 study showed previously untreated patients aged 70 years or younger treated with ibrutinib plus rituximab…
Janssen India launches Invokana to treat type II diabetes
Invokana has been shown to reduce glucose levels in adults who have previously not been able to achieve adequate control through…